Takeru Nambu

409 total citations
10 papers, 177 citations indexed

About

Takeru Nambu is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Takeru Nambu has authored 10 papers receiving a total of 177 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Immunology. Recurrent topics in Takeru Nambu's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Takeru Nambu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Takeru Nambu collaborates with scholars based in Japan, United States and Singapore. Takeru Nambu's co-authors include Akinobu Hamada, Hideyuki Saito, Tatsuya Kawaguchi, Reiko Nakashima, Hiroaki Mitsuya, Genki Nakamura, Kentaro Horikawa, Tomoyuki Igawa, Atsuhiko Maeda and Yuki Iwayanagi and has published in prestigious journals such as The Journal of Immunology, Cancer Science and Biological and Pharmaceutical Bulletin.

In The Last Decade

Takeru Nambu

10 papers receiving 169 citations

Peers

Takeru Nambu

HEMAT

GENET

RNMI

ONCOL

Christos Demosthenous Greece

Ryszard Pogłód Poland

Irene Dogliotti Italy

Sung-Soo Yoon South Korea

Gracia Martínez Brazil

Juan Manuel Alonso‐Domínguez Spain

Mats Björeman Sweden

Angela Cuoghi Italy

Olga Samoylova Russia

Leah Gehrs United States

Christos Demosthenous Greece

Takeru Nambu

77 ×0.8

HEMAT

64 ×0.9

GENET

71 ×1.4

7 ×0.2

RNMI

61 ×1.7

ONCOL

Citations per year, relative to Takeru Nambu Takeru Nambu (= 1×) peers Christos Demosthenous

Countries citing papers authored by Takeru Nambu

Since Specialization

Citations

This map shows the geographic impact of Takeru Nambu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeru Nambu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeru Nambu more than expected).

Fields of papers citing papers by Takeru Nambu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeru Nambu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeru Nambu. The network helps show where Takeru Nambu may publish in the future.

Co-authorship network of co-authors of Takeru Nambu

This figure shows the co-authorship network connecting the top 25 collaborators of Takeru Nambu. A scholar is included among the top collaborators of Takeru Nambu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeru Nambu. Takeru Nambu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Sampei, Zenjiro, Christine X. Koo, Ying Xiu Toh, et al.. (2023). Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent Enhancement. Antibodies. 12(2). 36–36. 3 indexed citations

Kuramochi, Taichi, Siok Wan Gan, Adrian W. S. Ho, et al.. (2022). Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants. mAbs. 14(1). 2040350–2040350. 3 indexed citations

Hori, Yuji, Hitoshi Katada, Yuki Noguchi, et al.. (2022). Elimination of plasma soluble antigen in cynomolgus monkeys by combining pH-dependent antigen binding and novel Fc engineering. mAbs. 14(1). 2068213–2068213. 6 indexed citations

Nakamura, Genki, et al.. (2020). Predicting Method for the Human Plasma Concentration–Time Profile of a Monoclonal Antibody from the Half-life of Non-human Primates. Biological and Pharmaceutical Bulletin. 43(5). 823–830. 6 indexed citations

Maeda, Atsuhiko, Yuki Iwayanagi, Kenta Haraya, et al.. (2017). Identification of human IgG1 variant with enhanced FcRn binding and without increased binding to rheumatoid factor autoantibody. mAbs. 9(5). 844–853. 16 indexed citations

Iwayanagi, Yuki, Tomoyuki Igawa, Atsuhiko Maeda, et al.. (2015). Inhibitory FcγRIIb-Mediated Soluble Antigen Clearance from Plasma by a pH-Dependent Antigen-Binding Antibody and Its Enhancement by Fc Engineering. The Journal of Immunology. 195(7). 3198–3205. 28 indexed citations

Uchida, Takashi, et al.. (2011). High-Performance Liquid Chromatographic Assay for the Determination of Nilotinib in Human Plasma. Biological and Pharmaceutical Bulletin. 34(7). 1126–1128. 22 indexed citations

Nambu, Takeru, Akinobu Hamada, Reiko Nakashima, et al.. (2011). Association of SLCO1B3 Polymorphism with Intracellular Accumulation of Imatinib in Leukocytes in Patients with Chronic Myeloid Leukemia. Biological and Pharmaceutical Bulletin. 34(1). 114–119. 33 indexed citations

Nambu, Takeru, Norie Araki, Akihiko Kuniyasu, et al.. (2009). Contribution of BCR–ABL‐independent activation of ERK1/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells. Cancer Science. 101(1). 137–142. 23 indexed citations

10.

Kawaguchi, Tatsuya, Akinobu Hamada, Reiko Nakashima, et al.. (2009). Relationship between an effective dose of imatinib, body surface area, and trough drug levels in patients with chronic myeloid leukemia. International Journal of Hematology. 89(5). 642–648. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact